Medial temporal lobe atrophy in Alzheimer's disease/mild cognitive impairment with depression

British Journal of Radiology

Volumn 87, Issue 1042, 2014, Pages

  Dhikav, V ^a   Sethi, M ^a   Anand, K S ^a  

^a GURU GOBIND SINGH INDRAPRASTHA UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; CLINICAL ARTICLE; DEPRESSION; DISEASE DURATION; FEMALE; HUMAN; MALE; MEDIAL TEMPORAL LOBE ATROPHY; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; RATING SCALE; SCHELTENS VISUAL RATING SCALE; TEMPORAL LOBE; ATROPHY; COMPLICATION; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

AGED; ALZHEIMER DISEASE; ATROPHY; DEPRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; TEMPORAL LOBE;

EID: 84907495125     PISSN: 00071285     EISSN: 1748880X     Source Type: Journal    
DOI: 10.1259/bjr.20140150     Document Type: Article

References (21)

1. Nozaki S, Yoshimura K, Mimura M. Depression and dementia: perspectives from clinical studies. [In Japanese.] Brain Nerve 2012; 64: 1387-97.
2. Kessing LV. Depression and the risk for dementia. Curr Opin Psychiatry 2012; 25: 457-61. doi: 10.1097/ YCO.0b013e328356c368
3. Bhalla RK, Butters MA, Becker JT, Houck PR, Snitz BE, Lopez OL, et al. Patterns of mild cognitive impairment after treatment of depression in the elderly. Am J Geriatr Psychiatry 2009; 17: 308-16. doi: 10.1097/JGP.0b013e318190b8d8
4. Panza F, Frisardi V, Capurso C, D'Introno A, Colacicco AM, Imbimbo BP, et al. Late-life depression, mild cognitive impairment, and dementia: possible continuum? Am J Geriatr Psychiatry 2010; 18: 98-116. doi: 10.1097/JGP.0b013e3181b0fa13
5. Muliyala KP, Varghese M. The complex relationship between depression and dementia. Ann Indian Acad Neurol 2010; 13(Suppl. 2): S69-73. doi: 10.4103/0972-2327.74248
6. Butters MA, Young JB, Lopez O, Aizenstein HJ, Mulsant BH, Reynolds CF 3rd, et al. Pathways linking late-life depression to persistent cognitive impairment and dementia. Dialogues Clin Neurosci 2008; 10: 345-57.
7. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A 1996; 93: 3908-13.
8. Eker C, Gonul AS. Volumetric MRI studies of the hippocampus in major depressive disorder: meanings of inconsistency and directions for future research. World J Biol Psychiatry 2010; 11: 19-35. doi: 10.1080/15622970902737998
9. McKinnon MC, Yucel K, Nazarov A, MacQueen GM. A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. J Psychiatry Neurosci 2009; 34: 41-54.
10. Kessing LV, Forman JL, Andersen PK. Do continued antidepressants protect against dementia in patients with severe depressive disorder? Int Clin Psychopharmacol 2011; 26: 316-22. doi: 10.1097/YIC.0b013e32834ace0f
11. Tae WS, Kim SS, Lee KU, Nam EC, Kim KW. Validation of hippocampal volumes measured using a manual method and two automated methods (FreeSurfer and IBASPM) in chronic major depressive disorder. Neuroradiology 2008; 50: 569-81. doi: 10.1007/s00234-008-0383-9
12. Dhikav V, Anand K. Potential predictors of hippocampal atrophy in Alzheimer's disease. Drugs Aging 2011; 28: 1-11. doi: 10.2165/11586390-000000000-00000
13. Dhikav V, Anand KS. Glucocorticoids may initiate Alzheimer's disease: a potential therapeutic role for mifepristone (RU-486). Med Hypotheses 2007; 68: 1088-92. doi: 10.1016/j.mehy.2006.09.038
14. Dhikav V, Anand KS. Is hippocampal atrophy a future drug target? Med Hypotheses 2007; 68: 1300-6. doi: 10.1016/j.mehy.2006.09.040
15. Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, et al. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992; 55: 967-72.
16. Lloyd AJ, Ferrier IN, Barber R, Gholkar A, Young AH, O'Brien JT. Hippocampal volume change in depression: late-and early-onset illness compared. Br J Psychiatry 2004; 184: 488-95.
17. Lyketsos CG, Sheppard JM, Steele CD, Kopunek S, Steinberg M, Baker AS, et al. Randomized, placebo-controlled, doubleblind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: initial results from the Depression in Alzheimer's Disease study. Am J Psychiatry 2000; 157: 1686-9.
18. Korf ES, Wahlund LO, Visser PJ, Scheltens P. Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment. Neurology 2004; 63: 94-100.
19. Wright SL, Persad C. Distinguishing between depression and dementia in older persons: neuropsychological and neuropathological correlates. J Geriatr Psychiatry Neurol 2007; 20: 189-98. doi: 10.1177/0891988707308801
20. Enache D, Winblad B, Aarsland D. Depression in dementia: epidemiology, mechanisms, and treatment. Curr Opin Psychiatry 2011; 24: 461-72. doi: 10.1097/YCO.0b013e32834bb9d4
21. Geerlings MI, den Heijer T, Koudstaal PJ, Hofman A, Breteler MM. History of depression,depressive symptoms, and medial temporal lobe atrophy and the risk of Alzheimer disease. Neurology 2008; 70: 1258-64. doi: 10.1212/01.wnl.0000308937.30473.d1